IRIS
DAVID, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.114
AS - Asia 2.845
EU - Europa 1.745
SA - Sud America 338
AF - Africa 105
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.153
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.041
SG - Singapore 1.171
CN - Cina 824
IE - Irlanda 362
VN - Vietnam 358
BR - Brasile 261
SE - Svezia 250
FI - Finlandia 242
IT - Italia 237
HK - Hong Kong 219
DE - Germania 198
UA - Ucraina 170
TR - Turchia 116
NL - Olanda 88
FR - Francia 75
ZA - Sudafrica 75
CA - Canada 56
RU - Federazione Russa 41
GB - Regno Unito 39
BD - Bangladesh 26
AR - Argentina 24
IN - India 23
IQ - Iraq 17
EC - Ecuador 16
UZ - Uzbekistan 15
BE - Belgio 12
VE - Venezuela 10
ES - Italia 9
PH - Filippine 9
CL - Cile 8
PK - Pakistan 8
MX - Messico 7
PL - Polonia 7
TH - Thailandia 7
TN - Tunisia 7
ID - Indonesia 6
LB - Libano 6
JO - Giordania 5
JP - Giappone 5
MA - Marocco 5
PE - Perù 5
PY - Paraguay 5
AT - Austria 4
CO - Colombia 4
KR - Corea 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
BO - Bolivia 3
CI - Costa d'Avorio 3
DZ - Algeria 3
EG - Egitto 3
JM - Giamaica 3
KE - Kenya 3
OM - Oman 3
TW - Taiwan 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
EU - Europa 2
IL - Israele 2
KZ - Kazakistan 2
LU - Lussemburgo 2
PA - Panama 2
UY - Uruguay 2
BB - Barbados 1
BG - Bulgaria 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
Totale 8.153
Salva come PNG Salva come JPEG
Città #
Singapore 568
Dublin 360
Ashburn 354
Chandler 347
Santa Clara 323
Jacksonville 303
San Jose 289
Hong Kong 210
Beijing 201
Ho Chi Minh City 111
Izmir 106
Boardman 92
San Mateo 92
Nanjing 87
Dearborn 82
Hanoi 78
Princeton 77
Johannesburg 71
Ann Arbor 64
Lauterbourg 64
Los Angeles 57
Wilmington 50
Toronto 44
Hebei 42
Shenyang 40
Parma 39
Dallas 37
Jinan 35
New York 35
Helsinki 32
Moscow 32
Shanghai 32
Tianjin 24
Columbus 23
Kunming 23
Nanchang 23
Buffalo 22
Haiphong 22
São Paulo 21
Changsha 19
Bologna 18
Bremen 16
Council Bluffs 16
Jiaxing 15
Munich 15
Tashkent 15
Woodbridge 15
Des Moines 13
Hefei 13
Seattle 13
Zhengzhou 13
Brussels 11
Da Nang 11
Guangzhou 11
Genoa 10
Haikou 10
Norwalk 9
Nuremberg 9
Brooklyn 8
Frankfurt am Main 8
Chengdu 7
Hangzhou 7
Hải Dương 7
San Francisco 7
The Dalles 7
Turku 7
Warsaw 7
Baghdad 6
Brasília 6
Fuzhou 6
Goiânia 6
Houston 6
Montreal 6
Ningbo 6
Rome 6
Stockholm 6
Taiyuan 6
Atlanta 5
Can Tho 5
Caxias do Sul 5
Chicago 5
Duncan 5
Guayaquil 5
Kyiv 5
Lima 5
London 5
Napoli 5
Ninh Bình 5
Rio de Janeiro 5
Rockville 5
Amman 4
Auburn Hills 4
Bangkok 4
Belo Horizonte 4
Biên Hòa 4
Borås 4
Buenos Aires 4
Denver 4
Dhaka 4
Düsseldorf 4
Totale 4.994
Salva come PNG Salva come JPEG
Nome #
IL PROGETTO PIRP (PREVENZIONE INSUFFICIENZA RENALE PROGRESSIVA) DELLA REGIONE EMILIA-ROMAGNA: ANALISI DEI RISULTATI PRELIMINARI 221
CALCIFICASSI ESITATA IN GUARIGIONE DOPO TERAPIA CON TIOSOLFATO 164
IMPROVEMENT OF INTRADIALYTIC TOLERANCE WITH LOW VOLUME DIALYSIS AND BICARBONATE BUFFERING OF DIALYSATE. 144
CLINICAL POLICIES ON THE MANAGEMENT OF CHRONIC KIDNEY DISEASE PATIENTS IN ITALY 143
Burnout in health care providers of dialysis service in Northern Italy—a multicentre study 141
2-h DIALYSIS: A REALISTIC GOAL ? 135
A SIMPLE APPROACH FOR ASSESSING EQUILIBRATED KT/VB2M ON A ROUTINE BASIS. 133
Clinical heterogeneity of hereditary coproporphyria: diagnostic usefulness of biochemical studies. Study of a familial case 133
CLINICAL EFFECTS OF ONLINE DIALYSATE AND INFUSION FLUIDS 132
ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION INDUCES PROINFLAMMATORY ACTIVITY IN HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS. 132
Albumin loss in on-line haemodiafiltration 131
ADHERENCE OF HUMAN MONOCYTES TO HAEMODIALYSIS MEMBRANES 131
ALTERNATIVE PATHWAY ACTIVATION OF COMPLEMENT BY CULTURED HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS 131
High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results 129
Bacterial contamination of the dialysis fluid in different dialyzing machines 127
THE SIGNIFICANCE OF THE HBeAG/ANTI HBe SYSTEM IN HEMODIALYSISPATIENTS. A MULTICENTER STUDY. 125
BEHAVIOUR OF B2-MICROGLOBULIN REMOVAL WITH DIFFERENT DIALYSIS SCHEDULES 123
HEMOFILTRATION: PREDILUTION VERSUS POSTDILUTION 122
GLUCOSE METABOLISM AND LARGER MOLECULE REMOVAL IN LONG-TERM HIGH-EFFICIENCY HEMOFILTRATION 121
ADEQUACY OF TREATMENT OF UREMIA IN THE NINETIES 121
Severe acute valproic acid intoxication successfully treated with hemodiafiltration without hemoperfusion 120
BASIC THERAPEUTIC REQUIREMENTS IN THE TREATMENT OF SEPSIS IN ACUTE RENAL FAILURE 120
An overview of hemodialysis and oxidant stress 118
STORIA E PRINCIPI BIOFISICI GENERALI DELLE TECNICHE CONVETTIVE 118
Sarcoid granulomatous nephritis with isolated and reversible renal failure. A case report. 113
A clinical stratification tool for chronic kidney disease progression rate based on classification tree analysis 113
ASSOCIAZIONE TRA LIVELLI DI ACIDO URICO E RISCHIO DI PROGRESSIONE DELL’INSUFFICIENZA RENALE O DI MORTE PER OGNI CAUSA 112
L'emodialisi e la dialisi peritoneale 110
CYCLOSPORIN A AND DRUG INTERACTION. 110
Identification of operational clues to dry weight prescription in hemodialysis using bioimpedance vector analysis 109
PRESENTAZIONE DI UNA FORMULA PER IL CALCOLO IMMEDIATO DEL KT/V DELLA BETA2 MICROGLOBULINA 109
Aliskiren Combined with Losartan in Type 2 Diabetesand Nephropathy 109
HEMOFILTRATION AND HEMODIAFILTRATION REDUCEINTRADIALYTIC HYPOTENSION IN ESRD 106
CORRECTION OF UREMIC ACIDOSIS BY HEMODIALYSIS 106
ROLE OF PLATELET ACTIVATING FACTOR IN HEMODIALYSIS. 105
Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change 105
Organic contamination in dialysis water: trichloroethylene as a model compound. 104
DANGER OF UNNECESSARILY PROLONGED DIALYSIS SESSION: CARPAL TUNNEL SYNDROME 103
Variable radiological lung nodule evaluation leads to divergent management recommendations 103
REVERSIBLE ACUTE CYCLOSPORINE NEPHROTOXICITY INDUCED BY COLCHICINE ADMINISTRATION 103
Tolerance to ultrafiltration in hemodialysis 102
Alterations of the cytokine network in hemodialysis 101
PRE-POSTDILUTION HEMOFILTRATION 99
Hemodiafiltration and high-flux hemodialysis with polyethersulfone membranes 97
IL REBOUND E IL KT/V EQUILIBRATO DELLA BETA2 MICROGLOBULINA NELLE DIFFERENTI TECNICHE AD ALTO FLUSSO. 97
Long-term outcome and clinical significance of orthostatic proteinuria. 96
Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC). 96
Urea in Exhaled Breath Condensate of Uraemics and Patients with Chronic Airway Diseases 95
EFFECTS OF ADD-ON FLUVASTATIN THERAPY IN PATIENTS WITH CHRONIC PROTEINURIC NEPHROPATHY ON DUAL RENIN-ANGIOTENSIN SYSTEM BLOCKADE: THE ESPLANADE TRIAL 94
Disinfection in dialysis, using aldehydes. Theoretical considerations and practical use 93
THE EMILIA-ROMAGNA REGION PIRP PROGRAMME ( PREVENTION IN PROGRESSION OF PROGRESSIVE RENAL INSUFFICIENCY) 93
Preventing the epidemic of cardiovascular disease: new perspectives in extracorporeal substitutive treatment 92
Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS 91
EFFETTI DELLA TERAPIA PROLUNGATA CON CALCITRIOLO SU FGF23 E SUL METABOLISMO CALCIO-FOSFORICO NELL’IRC. 91
Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial. 90
Phosphate levels in patients treated with low-flux haemodialysis, pre-dilution haemofiltration and haemodiafiltration: post hoc analysis of a multicentre, randomized and controlled trial 90
Dialysis strategies 89
THE HEMATOPOIETIC SYSTEM IN RENAL FAILURE 89
TERAPIA CON CALCIFEDIOLO NEI PAZIENTI CON CKD E DEFICIT DI VITAMINA D. 88
IRON-REPLETE HAEMODIALYSIS PATIENTS DO NOT REQUIRE HIGHER ERYTHROPOIETIN DOSAGES WHEN CONVERTING FROM SUBCUTANEOUS TO INTRAVENOUS ADMINISTRATION. RESULTS OF THE ITALIAN STUDY ON ERYTHROPOIETIN CONVERTING (ISEC). 87
Immunological aspects of urinary tract infections 86
TANDEM PLASMA-EXCHANGE (PE) DIALYSIS. UNA VARIANTE SEMPLIFICATA. 86
COMPARISON OF 3 AUTOMATED ASSAYS FOR C-REACTIVE PROTEIN IN END-STAGE RENAL DISEASE: CLINICAL AND EPIDEMIOLOGICAL IMPLICATIONS 84
PRODUCTION OF PLATELET ACTIVATING FACTOR BY HUMAN NEUTROPHILS AFTER BACKFILTRATION OF ENDOTOXIN CONTAMINATED DIALYSATE. 83
Renal insufficiency (RI) evolving to a definitive cure in sarcoidosic granulomatous nephritis (SGN) 83
Contribution of echotomography (ET) to transcutaneous renal needle-biopsy (RNB) and to the detection of possible complications 82
RISULTATI DELL’ECOCARDIOGRAFIA ESOFAGEA E TRANSTORACICA IN PAZIENTI IN EMODIALISI SENZA CARDIOPATIE CLINICAMENTE RILEVANTI 82
EFFETTI A MEDIO TERMINE DEL CALCITRIOLO NEI PAZIENTI CON INSUFFICIENZA RENALE CRONICA E IPERPARATIROIDISMO LIEVE-MODERATO 82
THE COST/BENEFIT RATIO OF RENAL REPLACEMENT THERAPY 81
Determination of urinary albumin excretion in subclinical forms of glomerulonephritis by electroimmunodiffusion. 81
QUANTIFICAZIONE DELL’EFFICIENZA DIALITICA PER L’UREA E PER LA BETA2 MICROGLOBULINA NELLE DIFFERENTI TECNICHE AD ALTO FLUSSO. 80
PREDILUTION HEMOFILTRATION. CLINICAL EXPERIENCE AND REMOVAL OF SMALL MOLECULAR WEIGHT SOLUTES 79
THE ROLE OF PLATELET-ACTIVATING FACTOR IN THE BIOCOMPATIBILITY OF HEMODIALYSIS MEMBRANES 78
HEMOFILTRATION-INDUCED SERUM MODIFICATIONS IN THE PATTERN OF LARGER MOLECULES 78
IN VITRO AND IN VIVO BIOCOMPATIBILITY OF SUBSTITUTED CELLULOSE AND SYNTHETIC MEMBRANES 73
THE ROLE OF ADSORPTION IN 2-MICROGLOBULIN REMOVAL 71
SARCOID GRANULOMATOUS NEPHRITIS WITH ISOLATED AND REVERSIBLE RENAL FAILURE. A CASE REPORT. 68
Totale 8.162
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.444
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202193 0 0 0 0 0 0 0 0 0 7 83 3
2021/2022359 2 1 9 6 10 7 51 62 19 47 39 106
2022/20231.243 143 110 78 82 109 151 5 75 441 3 28 18
2023/2024326 29 56 12 9 37 67 0 29 9 15 25 38
2024/20251.607 33 89 95 43 194 286 7 65 217 153 125 300
2025/20262.628 272 246 309 164 463 171 349 61 396 197 0 0
Totale 8.162